Cargando…

Validation of a fornix depth measurer: a putative tool for the assessment of progressive cicatrising conjunctivitis

BACKGROUND/AIMS: Documentation of conjunctival forniceal foreshortening in cases of progressive cicatrising conjunctivitis (PCC) is important in ascertaining disease stage and progression. Lower fornix shortening is often documented subjectively or semi-objectively, whereas upper forniceal obliterat...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Geraint P, Saw, Valerie P J, Saeed, Tariq, Evans, Simon T, Cottrell, Paul, Curnow, S John, Nightingale, Peter, Rauz, Saaeha
Formato: Texto
Lenguaje:English
Publicado: BMJ Group 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3099360/
https://www.ncbi.nlm.nih.gov/pubmed/20956276
http://dx.doi.org/10.1136/bjo.2010.188011
_version_ 1782204055602331648
author Williams, Geraint P
Saw, Valerie P J
Saeed, Tariq
Evans, Simon T
Cottrell, Paul
Curnow, S John
Nightingale, Peter
Rauz, Saaeha
author_facet Williams, Geraint P
Saw, Valerie P J
Saeed, Tariq
Evans, Simon T
Cottrell, Paul
Curnow, S John
Nightingale, Peter
Rauz, Saaeha
author_sort Williams, Geraint P
collection PubMed
description BACKGROUND/AIMS: Documentation of conjunctival forniceal foreshortening in cases of progressive cicatrising conjunctivitis (PCC) is important in ascertaining disease stage and progression. Lower fornix shortening is often documented subjectively or semi-objectively, whereas upper forniceal obliteration is seldom quantified. Although tools such as fornix depth measurers (FDMs) have been described, their designs limit upper fornix measurement. The purpose of this study was to custom-design a FDM to evaluate the upper fornix and to assess variability in gauging fornix depth. METHODS: A polymethylmethacrylate FDM was constructed using industry-standard jewellery computer software and machinery. Two observers undertook a prospective independent evaluation of central lower fornix depth in a heterogeneous cohort of patients with clinically normal and abnormal conjunctival fornices both subjectively and by using the FDM (in mm). Upper central fornix depth was also measured. Agreement was assessed using Bland–Altman plots. RESULTS: Fifty-one eyes were evaluated. There was 100% intraobserver agreement to within 1 mm for each observer for lower fornix measurement. The mean difference in fornix depth loss using the FDM between observer 1 and 2 was 1.19%, with 95% confidence of agreement (±2SD) of −15% to +20%. In total, 86% (44/51) of measurements taken by the two observers agreed to within 10% of total lower fornix depth (ie, ±1 mm) versus only 63% (32/51) of the subjective measurements. Mean upper fornix difference was 0.57 mm, with 95% confidence of agreement of between −2 and +3 mm. CONCLUSIONS: This custom-designed FDM is well tolerated by patients and shows low intraobserver and interobserver variability. This enables repeatable and reproducible measurement of upper and lower fornix depths, facilitating improved rates of detection and better monitoring of progression of conjunctival scarring.
format Text
id pubmed-3099360
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BMJ Group
record_format MEDLINE/PubMed
spelling pubmed-30993602011-05-31 Validation of a fornix depth measurer: a putative tool for the assessment of progressive cicatrising conjunctivitis Williams, Geraint P Saw, Valerie P J Saeed, Tariq Evans, Simon T Cottrell, Paul Curnow, S John Nightingale, Peter Rauz, Saaeha Br J Ophthalmol Clinical Science BACKGROUND/AIMS: Documentation of conjunctival forniceal foreshortening in cases of progressive cicatrising conjunctivitis (PCC) is important in ascertaining disease stage and progression. Lower fornix shortening is often documented subjectively or semi-objectively, whereas upper forniceal obliteration is seldom quantified. Although tools such as fornix depth measurers (FDMs) have been described, their designs limit upper fornix measurement. The purpose of this study was to custom-design a FDM to evaluate the upper fornix and to assess variability in gauging fornix depth. METHODS: A polymethylmethacrylate FDM was constructed using industry-standard jewellery computer software and machinery. Two observers undertook a prospective independent evaluation of central lower fornix depth in a heterogeneous cohort of patients with clinically normal and abnormal conjunctival fornices both subjectively and by using the FDM (in mm). Upper central fornix depth was also measured. Agreement was assessed using Bland–Altman plots. RESULTS: Fifty-one eyes were evaluated. There was 100% intraobserver agreement to within 1 mm for each observer for lower fornix measurement. The mean difference in fornix depth loss using the FDM between observer 1 and 2 was 1.19%, with 95% confidence of agreement (±2SD) of −15% to +20%. In total, 86% (44/51) of measurements taken by the two observers agreed to within 10% of total lower fornix depth (ie, ±1 mm) versus only 63% (32/51) of the subjective measurements. Mean upper fornix difference was 0.57 mm, with 95% confidence of agreement of between −2 and +3 mm. CONCLUSIONS: This custom-designed FDM is well tolerated by patients and shows low intraobserver and interobserver variability. This enables repeatable and reproducible measurement of upper and lower fornix depths, facilitating improved rates of detection and better monitoring of progression of conjunctival scarring. BMJ Group 2010-10-17 2011-06 /pmc/articles/PMC3099360/ /pubmed/20956276 http://dx.doi.org/10.1136/bjo.2010.188011 Text en © 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.
spellingShingle Clinical Science
Williams, Geraint P
Saw, Valerie P J
Saeed, Tariq
Evans, Simon T
Cottrell, Paul
Curnow, S John
Nightingale, Peter
Rauz, Saaeha
Validation of a fornix depth measurer: a putative tool for the assessment of progressive cicatrising conjunctivitis
title Validation of a fornix depth measurer: a putative tool for the assessment of progressive cicatrising conjunctivitis
title_full Validation of a fornix depth measurer: a putative tool for the assessment of progressive cicatrising conjunctivitis
title_fullStr Validation of a fornix depth measurer: a putative tool for the assessment of progressive cicatrising conjunctivitis
title_full_unstemmed Validation of a fornix depth measurer: a putative tool for the assessment of progressive cicatrising conjunctivitis
title_short Validation of a fornix depth measurer: a putative tool for the assessment of progressive cicatrising conjunctivitis
title_sort validation of a fornix depth measurer: a putative tool for the assessment of progressive cicatrising conjunctivitis
topic Clinical Science
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3099360/
https://www.ncbi.nlm.nih.gov/pubmed/20956276
http://dx.doi.org/10.1136/bjo.2010.188011
work_keys_str_mv AT williamsgeraintp validationofafornixdepthmeasureraputativetoolfortheassessmentofprogressivecicatrisingconjunctivitis
AT sawvaleriepj validationofafornixdepthmeasureraputativetoolfortheassessmentofprogressivecicatrisingconjunctivitis
AT saeedtariq validationofafornixdepthmeasureraputativetoolfortheassessmentofprogressivecicatrisingconjunctivitis
AT evanssimont validationofafornixdepthmeasureraputativetoolfortheassessmentofprogressivecicatrisingconjunctivitis
AT cottrellpaul validationofafornixdepthmeasureraputativetoolfortheassessmentofprogressivecicatrisingconjunctivitis
AT curnowsjohn validationofafornixdepthmeasureraputativetoolfortheassessmentofprogressivecicatrisingconjunctivitis
AT nightingalepeter validationofafornixdepthmeasureraputativetoolfortheassessmentofprogressivecicatrisingconjunctivitis
AT rauzsaaeha validationofafornixdepthmeasureraputativetoolfortheassessmentofprogressivecicatrisingconjunctivitis